Tuesday, December 11, 2018

Clinical Trial for Parkinson's Disease sponsored by Cure Click


                                         
        https://curec.lk/2CZN7S       
                       

    Hashtags    
#parkinsons #PD #parkinsonsdisease #levodopa #sponsored #cureclick #ad 

Today, researchers are evaluating an investigational drug that focuseson the earliest stages of Parkinson’s disease that may potentially offer a new option for recently diagnosed patients.
If you have been recently diagnosed with Parkinson’s disease, you may want to consider a newly opened study. It is evaluating the safety and potential efficacy of an investigational drug that targets alpha-synuclein (α-syn), a molecule associated with Parkinson’s disease. The investigational drug is being studied to see if it may potentially help to slow or reduce disease progression.
For people who:
-- Have been diagnosed with Parkinson's disease in the last 3 years
-- Are 40 to 80 years of age
-- Have not received levodopa in the last 12 weeks
Learn more! #sponsored #cureclick



Post a Comment